The heparin binding motif of endostatin mediates its interaction with receptor nucleolin

Biochemistry

Volumn 48, Issue 49, 2009, Pages 11655-11663

  Fu, Yan ^a   Chen, Yang ^a   Luo, Xu ^a   Liang, Yun ^a   Shi, Hubing ^a   Gao, Lei ^a   Zhan, Shunli ^a   Zhou, Daifu ^a   Luo, Yongzhang ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITORS; ANTI-ANGIOGENIC ACTIVITY; ANTI-TUMOR ACTIVITIES; ANTIANGIOGENIC; ARGININE RESIDUE; BIOLOGICAL ACTIVITIES; BIOLOGICAL FUNCTIONS; ENDOSTATINS; FUNCTIONAL RECEPTORS; HEPARIN BINDING; IN-VITRO; IN-VIVO; NUCLEOLIN; POINT MUTAGENESIS; POINT MUTATIONS;

AMINO ACIDS; BLOOD VESSEL PROSTHESES; PLANTS (BOTANY); POLYSACCHARIDES; SELF ASSEMBLY;

ENDOTHELIAL CELLS;

ALANINE; ARGININE; ENDOSTATIN; HEPARIN; NUCLEOLIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; DRUG BINDING; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; MOUSE; MUTAGENESIS; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN INTERACTION;

ALANINE; AMINO ACID MOTIFS; AMINO ACID SUBSTITUTION; ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; ARGININE; CELL LINE, TUMOR; ENDOSTATINS; HEPARIN; HUMANS; MICE; MICE, INBRED C57BL; MUTAGENESIS, SITE-DIRECTED; PHOSPHOPROTEINS; POINT MUTATION; PROTEIN BINDING; PROTEIN CONFORMATION; RNA-BINDING PROTEINS;

EID: 71549142577     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi901265z     Document Type: Article

References (28)

1. O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., and Folkman, J. (1997) Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277-285. (Pubitemid 28015876)
2. Hohenester, E., Sasaki, T., Olsen, B. R., and Timpl, R. (1998) Crystal structure of the angiogenesis inhibitor endostatin at 1.5 angstrom resolution. EMBO J. 17, 1656-1664. (Pubitemid 28119119)
3. Sasaki, T., Fukai, N., Mann, K., Gohring, W., Olsen, B. R., and Timpl, R. (1998) Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin. EMBO J. 17, 4249-4256. (Pubitemid 28362615)
4. Sasaki, T., Larsson, H., Kreuger, J., Salmivirta, M., Claesson-Welsh, L., Lindahl, U., Hohenester, E., and Timpl, R. (1999) Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin. EMBO J. 18, 6240-6248. (Pubitemid 29533228)
5. Olsson,A.K., Johansson, I.,Akerud, H., Einarsson, B., Christofferson, R., Sasaki, T., Timpl, R., and Claesson-Welsh, L. (2004) The minimal active domain of endostatin is a heparin-binding motif that mediates inhibition of tumor vascularization. Cancer Res. 64, 9012-9017. (Pubitemid 39665511)
6. Ginisty, H., Sicard, H., Roger, B., and Bouvet, P. (1999) Structure and functions of nucleolin. J. Cell Sci. 112 (Part 6), 761-772.
7. Ginisty, H., Amalric, F., and Bouvet, P. (1998) Nucleolin functions in the first step of ribosomal RNA processing. EMBO J. 17, 1476-1486. (Pubitemid 28105526)
8. Erard, M. S., Belenguer, P., Caizergues-Ferrer, M., Pantaloni, A., and Amalric, F. (1988) A major nucleolar protein, nucleolin, induces chromatin decondensation by binding to histone H1. Eur. J. Biochem. 175, 525-530.
9. Kharrat, A., Derancourt, J., Doree, M., Amalric, F., and Erard, M. (1991) Synergistic effect of histone H1 and nucleolin on chromatin condensation in mitosis: Role of a phosphorylated heteromer. Biochemistry 30, 10329-10336.
10. Christian, S., Pilch, J., Akerman, M. E., Porkka, K., Laakkonen, P., and Ruoslahti, E. (2003) Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels. J. Cell Biol. 163, 871-878. (Pubitemid 37517893)
11. Huang, Y. J., Shi, H. B., Zhou, H., Song, X. M., Yuan, S. P., and Luo, Y. Z. (2006) The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin. Blood 107, 3564-3571.
12. Shi, H. B., Huang, Y. J., Zhou, H., Song, X. M., Yuan, S. P., Fu, Y., and Luo, Y. Z. (2007) Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin. Blood 110, 2899-2906. (Pubitemid 350006943)
13. Eder, J. P., Supko, J. G., Clark, J. W., Puchalski, T. A., Garcia-Carbonero, R., Ryan, D. P., Shulman, L. N., Proper, J., Kirvan, M., Rattner, B., Connors, S., Keogan, M. T., Janicek, M. J., Fogler, W. E., Schnipper, L., Kinchla, N., Sidor, C., Phillips, E., Folkman, J., and Kufe, D. W. (2002) Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily. J. Clin. Oncol. 20, 3772-3784.
14. Gaetzner, S., Deckers, M. M. L., Stahl, S., Lowik, C., Olsen, B. R., and Felbor, U. (2005) Endostatin's heparan sulfate-binding site is essential for inhibition of angiogenesis and enhances in situ binding to capillary-like structures in bone explants. Matrix Biol. 23, 557-561. (Pubitemid 40202754)
15. Folkman, J. (2007) Endostatin finds a new partner: Nucleolin. Blood 110, 2786-2787.
16. Sasaki, T., Larsson, H., Kreuger, J., Salmivirta, M., Claesson-Welsh, L., Lindahl, U., Hohenester, E., and Timpl, R. (1999) Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin. EMBO J. 18, 6240-6248. (Pubitemid 29533228)
17. Zhou, H., Wang, W., and Luo,Y. Z. (2005) Contributions of disulfide bonds in a nested pattern to the structure, stability, and biological functions of endostatin. J. Biol. Chem. 280, 11303-11312.
18. Ades, E. W., Candal, F. J., Swerlick, R. A., George, V. G., Summers, S., Bosse, D. C., and Lawley, T. J. (1992) HMEC-1: Establishment of an immortalized human microvascular endothelial cell line. J. Invest. Dermatol. 99, 683-690.
19. Li, B., Wu, X. Y., Zhou, H., Chen, Q. J., and Luo, Y. Z. (2004) Acidinduced unfolding mechanism of recombinant human endostatin. Biochemistry 43, 2550-2557. (Pubitemid 38327850)
20. Fu, Y., Wu, X. Y., Han, Q., Liang, Y., He, Y. B., and Luo, Y. Z. (2008) Sulfate stabilizes the folding intermediate more than the native structure of endostatin. Arch. Biochem. Biophys. 471, 232-239.
21. Dixelius, J., Larsson, H., Sasaki, T., Holmqvist, K., Lu, L., Engstrom, A., Timpl, R., Welsh, M., and Claesson-Welsh, L. (2000) Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis. Blood 95, 3403-3411. (Pubitemid 30428470)
22. Kreuger, J., Matsumoto, T., Vanwildemeersch, M., Sasaki, T., Timpl, R., Claesson-Welsh, L., Spillmann, D., and Lindahl, U. (2002) Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function. EMBO J. 21, 6303-6311. (Pubitemid 35448408)
23. Rehn, M., Veikkola, T., Kukk-Valdre, E., Nakamura, H., Ilmonen, M., Lombardo, C. R., Pihlajaniemi, T., Alitalo, K., and Vuori, K. (2001) Interaction of endostatin with integrins implicated in angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 98, 1024-1029.
24. MacDonald, N. J., Shivers, W. Y., Narum, D. L., Plum, S. M., Wingard, J. N., Fuhrmann, S. R., Liang, H., Holland-Linn, J., Chen, D. H. T., and Sim, B. K. L. (2001) Endostatin binds tropomyosin - A potential modulator of the antitumor activity of endostatin. J. Biol. Chem. 276, 25190-25196.
25. Karumanchi, S.A., Jha, V., Ramchandran, R., Karihaloo, A., Tsiokas, L., Chan, B., Dhanabal, M., Hanai, J. I., Venkataraman, G., Shriver, Z., Keiser, N., Kalluri, R., Zeng, H., Mukhopadhyay, D., Chen, R. L., Lander, A. D., Hagihara, K., Yamaguchi, Y., Sasisekharan, R., Cantley, L., and Sukhatme, V. P. (2001) Cell surface glypicans are low-affinity endostatin receptors. Mol. Cell 7, 811-822. (Pubitemid 32436441)
26. Kim, Y. M., Jang, J. W., Lee, O. H., Yeon, J., Choi, E. Y., Kim, K. W., Lee, S. T., and Kwon, Y. G. (2000) Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase 2. Cancer Res. 60, 5410-5413. (Pubitemid 30761251)
27. Wickstrom, S. A., Alitalo, K., and Keski-Oja, J. (2004)An endostatinderived peptide interacts with integrins and regulates actin cytoskeleton and migration of endothelial cells. J. Biol. Chem. 279, 20178-20185.
28. Reis, R. C. M., Schuppan, D., Barreto, A. C., Bauer, M., Bork, J. P., Hassler, G., and Coelho-Sampaio, T. (2005) Endostatin competes with bFGF for binding to heparin-like glycosaminoglycans. Biochem. Biophys. Res. Commun. 333, 976-983.